Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
35
datasets available to search
ShareScore release 0.9.0
Dataset results
35 results for “Bifidobacterium longum”
The Effects of Bifidobacterium Longum 1714® in a Population With Low Mood
ClinicalTrials.gov study NCT04925440. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients
ClinicalTrials.gov study NCT03815617. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto
ClinicalTrials.gov study NCT03078179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Data from: Protective role of nano-selenium-enriched Bifidobacterium longum in delaying the onset of streptozotocin-induced diabetes
Bifidobacterium longum (B. longum) could accumulate Selenium (Se) and nano-Se in the form of Se-B. longum and Nano-Se-B. longum, respectively. In this study, the effect of Nano-Se-B. longum in diabetic mice was evaluated. Physiological and metabolic parameters such as blood glucose, body weight, serum insulin level, intraperitoneal glucose tolerance test (IPGTT), food intake, water consumption, and urine output were evaluated. The expression of insulin signaling pathway-related proteins was evaluated by western blotting. Hematoxylin and eosin (H&E) was used for histological examination of the liver, pancreas, and kidney sections. Creatinine levels in serum (SCr) and blood urea nitrogen (BUN) were measured. Nano-Se-B. longum was the best in terms of delaying the onset of diabetes. Nano-Se-B. longum decreased blood glucose and body weight compared with those noted for the model group. IPGTT, food intake, water consumption, and urine output significantly increased and serum insulin levels significantly decreased in the model group compared with those in all the Nano-Se-B. longum-treated mice. Histological results showed that the Nano-Se-B. longum-treated mice were better than the model group mice in terms of pathological changes. The expression of insulin signaling pathway-related proteins was upregulated in the Nano-Se-B. longum-treated groups. A significant increase in SCr and BUN levels was noted in the model group. This study for the first time reported the dose-dependent preventive effect of Nano-Se-B. longum on the onset of diabetes and renal damage. The mechanism may be related to changes in insulin signaling.
Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults
ClinicalTrials.gov study NCT06140641. IPD Sharing: NO. Countries: 0. Publications: 1.
Data from: Protective role of nano-selenium-enriched Bifidobacterium longum in delaying the onset of streptozotocin-induced diabetes
Open the record for dataset details and reuse information.
Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
GEO Series GSE151933. Bifidobacterium longum subsp. infantis. 41 samples. Type: Expression profiling by high throughput sequencing.
Bifidobacterium longum mutant
GEO Series GSE16039. Bifidobacterium longum; Bifidobacterium longum NCC2705. 3 samples. Type: Expression profiling by array.
RNA sequencing of Bifidobacterium longum subsp. longum SC596 in response to various substrates
GEO Series GSE87697. Bifidobacterium longum. 18 samples. Type: Expression profiling by high throughput sequencing.
Next generation sequencing based transcriptomic analysis of oxidative stress response in Bifidobacterium longum BBMN68
GEO Series GSE65320. Bifidobacterium longum. 3 samples. Type: Expression profiling by high throughput sequencing.
mRNAseq profiling of Bifidobacterium longum-stimulated neonatal and adult T-cells
GEO Series GSE210336. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
RNA-Sequence analysis of enteroids incubating with Bifidobacterium longum
GEO Series GSE149592. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
Bifidobacterium longum subsp. infantis transcriptomes in response to various nitrogen sources
GEO Series GSE155078. Bifidobacterium longum subsp. infantis. 18 samples. Type: Expression profiling by high throughput sequencing.
Novel Genes and Metabolite Trends in Bifidobacterium longum ssp. infantis Bi-26 Involved in Metabolism of Human Milk Oligosaccharide 2’-fucosyllactose
GEO Series GSE122350. Bifidobacterium longum subsp. infantis. 12 samples. Type: Expression profiling by high throughput sequencing.
A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome
ClinicalTrials.gov study NCT05054309. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity
ClinicalTrials.gov study NCT04662502. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
ClinicalTrials.gov study NCT04422327. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Bifidobacterium Longum OLP-01 Supplement on Cognitive Function, Exercise Performance, Nutritional Status and Gut Microbiota in Stroke Patients
ClinicalTrials.gov study NCT05477732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
ClinicalTrials.gov study NCT06639516. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Bifidobacterium Longum for Skin Barrier Dysfunction in Obesity
ClinicalTrials.gov study NCT07184905. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.